RSS

Visterra

Visterra and Vir Biotechnology have entered into a research collaboration, exclusive licence and option agreement for the development and commercialisation of select programmes for infectious diseases. more

News

Clinical-stage biotechnology company, Visterra, has been awarded a research and development contract from the public-private partnership, Combating Antibiotic Resistant Bacteria Accelerator (CARB-X). more

News